Background. Children born at the start of the human immunodeficiency virus (HIV) epidemic and infected during the perinatal period are now young adults living with the virus. Naive T-lymphocyte restoration is essential for the maintenance of a diverse T-cell receptor repertoire and for immunity to pathogens.
The first generation of patients infected with human immunodeficiency virus type 1 (HIV-1) during the perinatal period has now reached adolescence or adulthood [1, 2] . Pediatric HIV infection differs from infection during adulthood in terms of clinical progression, pathophysiology, response to treatment, and the occurrence of viral replication during immune system development [2, 3] . Adolescence may be associated with poorer compliance with treatment in some patients, and physiological changes during puberty may affect the immune system [4] . The current immune and virological status of youths perinatally infected with HIV and their covariables have been the subject of limited investigations. The restoration and maintenance of the naive T-lymphocyte compartment is of importance for the future of these individuals because it is directly associated with the diversity of the T-cell receptor repertoire and critical for immunity to foreign antigens [5] . Previous pediatric studies have shown that CD4 T-lymphocyte recovery is driven principally by the de novo production of naive T lymphocytes in the thymus and that it declines with age and with HIV infection [6, 7] .
Our aim, within the ANRS-EP38-IMMIP study, was to provide more detailed knowledge of the pathophysiological characteristics of youths >15 years after perinatal infection. We previously reported that blood cell-associated HIV DNA levels in these youths, aged 15-24 years, were similar to those in infected adults. However, contrary to findings for adults, we found no negative correlation between HIV DNA level and CD4 T-cell counts in patients with suppressed viral replication [8] . This pattern of immunovirological equilibrium was observed in children and may result from sustained naive CD4 T-lymphocyte production by the thymus. We now report on the levels of naive CD4 (CD4 N ) and CD8 (CD8 N ) T lymphocytes and CD4 recent thymic emigrants (CD4 RTE ) in the HIV-infected youths included in the ANRS-EP38-IMMIP study and on the HIV disease factors associated with these 3 T-lymphocyte subsets.
METHODS

Patients
The characteristics of the 93 HIV-infected youths included in the ANRS-EP38-IMMIP are presented in Table 1 for the aviremic and viremic groups. The study was approved by the local ethics committees. All patients, as well as the legal guardians for those aged <18 years, received written information and signed an informed consent form. The inclusion criteria were (1) HIV-1 infection after vertical transmission, (2) aged ≥15 years, (3) no change in treatment status (treated or untreated) during the previous 6 months, and (4) introduction of care for HIV infection before 1996 to ensure that all patients had similar access to highly active antiretroviral therapy (HAART). A single 25-mL blood sample was taken for biological evaluations.
T Lymphocyte Phenotyping
CD4 and CD8 T-lymphocyte phenotypes were determined on fresh whole blood for 82 patients using combinations of the following antibodies: CD28-FITC, CD4-RD1, CD45RA-ECD, CD45RO-ECD, CD62L-PC5, CD27-PC5, CD4-PC7, and CD8-PC7 (Beckman Coulter, Villepinte, France). Data were collected on an FC500 cytometer and analyzed with CXP software (Beckman Coulter). CD4 N 
Virological Assays
HIV-1 reverse transcriptase and V3 Env sequences were obtained from blood cell HIV DNA as previously described (http:// www.hivfrenchresistance.org/). HIV-1 B and non-B subtypes were defined by phylogenetic analysis (http://www.hiv-web. lanl.gov). HIV-1 coreceptor usage was determined with the SVMGeno2pheno algorithm, with a 5.75% false-positive rate [12] . HIV RNA was quantified at the clinical sites, whereas HIV DNA was quantified at a central laboratory by real-time polymerase chain reaction with the Generic HIV-DNA Cell kit (Biocentric, Bandol, France) [8] . Serological tests for cytomegalovirus (CMV) were carried out on frozen plasma with the CMV IgG Liaison II kit (Diasorin, Antony, France).
Statistical Analysis
A full description of study variables has been provided elsewhere [8] . We studied univariable associations between Tlymphocyte subsets and variables defining current and past HIV disease, using the Wilcoxon test for categorical variables and Pearson correlation coefficients for continuous variables. Analyses were stratified on the basis of plasma HIV RNA detection, using a cutoff value of 80 HIV-RNA copies/mL to define aviremic and viremic patients. Multivariable analyses were performed by linear regression. Separate models were built for aviremic and viremic patients because of interactions between plasma HIV RNA detection and variables describing HIV disease history (data not shown). For each dependent variable, one full model was adjusted for noncollinear variables associated with the dependent variable in univariable analysis at P < .20. Age, as exposure factor of interest, was systematically included in all models, as was current HIV RNA level for viremic patients, whatever the P value. Economical models including only variables with P < .05 gave similar results, supporting the stability of analyses (data not shown).
Variables not included in the model because of collinearity are indicated in table footnotes. Analyses were conducted with SAS statistical software (version 9.2). P < .05 defined statistical significance. , 44%-64%) and 31% for CD8 N (IQR, 22%-44%). Patients who were aviremic at the time of the study tended to have a lower CD4 N percentage (55% vs 58%; P = .10) and had a significantly higher CD8 N percentage (39% vs 22%; P < .0001) than viremic patients ( Figure 1A and 1B). Naive T lymphocytes may be generated by the thymus or by peripheral proliferation. We investigated their origin by quantifying a correlate of thymic activity: the percentage of CD31 + CD4 RTE among naive CD4 T lymphocytes [13] . The median CD4 RTE percentage was 79% (IQR, 74%-83%). Aviremic patients had a significantly lower CD4 RTE percentage than viremic patients (77% vs 81%; P = .003; Figure 1C ). Thus, despite their shared developmental pathway, CD4 N , CD8 N , and CD4 RTE naive T lymphocytes are differentially associated with current HIV replication.
Associations Between CD4 N , CD8 N , and CD4 RTE T-Lymphocyte Levels and HIV Disease History in Aviremic Patients CD4 N , CD8 N , and CD4 RTE percentages were positively correlated with CD4 T-cell count in aviremic patients (CD4 N : r = 0.431, P = .001; CD8 N : r = 0.463, P = .0007; CD4 RTE : r = 0.520, P = .0007; Figure 1G -I) and with the CD4 T-cell percentage and CD4/CD8 ratio ( Table 2 ). CD4 N and CD8 N percentages were positively correlated with each other (r = 0.607; P < .0001; Figure 1D ) and were not correlated with CD4 RTE percentage (CD4 N : r = 0.278, P = .12; CD8 N : r = 0.226, P = .18; Figure 1E and 1F ). None of the 3 T-lymphocyte subsets was associated with ethnicity, HIV subtype, Centers for Disease Control and b Adjusted for the variables included in the model. The following variables with P < .20 in univariable analysis were not included in the model because of their associations with other independent variables: HIV-1 subtype was associated with CD4 T-cell count; HIV DNA levels and duration of the last period of HIV RNA < 500 copies/mL were associated with cumulative viremia. c Per year.
d Per log 10 HIV DNA copies/10 6 peripheral blood mononuclear cells.
e Per 100 cells/µL.
f Per 10 months.
g Per 10 000 days × log 10 HIV RNA copies/mL of plasma.
h Adjusted for variables included in the model. The following variables with P < .20 in univariable analysis were not included in the model because of their associations with other independent variables: HIV-1 subtype was associated with CD4 T-cell count; HIV-DNA levels were associated with cumulative duration of HAART over the last 10 years. i Adjusted for variables included in the model. The following variable with P < .20 in univariable analysis was not included in the model because of its associations with another independent variable: nadir CD4 T-cell % was associated with duration of CD4 T-cell % <15 during lifetime.
Prevention (CDC) stage, age at the time of the study, age at the time of nadir CD4 T-cell percentage, or age at the initiation of first HAART (Table 2 ). CD4 N percentage was positively correlated with cumulative viremia over the last 10 years (r = 0.335; P = .01). It also tended to be positively correlated with HIV DNA level in peripheral blood mononuclear cells and negatively correlated with the duration of the last period during which plasma HIV-RNA level was <500 copies/mL (Table 2) . Patients harboring X4R5 viruses had a significantly higher CD4 N percentage than patients harboring R5 viruses (medians, 44% vs 61%; P = .001). CD4 N percentage was not associated with sex, CMV seropositivity, nadir CD4 Tcell percentage, or the time for which CD4 T-cell percentage was <15% during the lifetime of the patient (Table 2 ).
CD8 N percentage was significantly higher in female than in male patients (medians, 45% vs 33%, respectively; P = .01) and was significantly higher in CMV-seronegative patients than in CMV-seropositive patients (medians, 45% vs 31%, respectively; P = .0001). There was a trend toward a higher CD8 N percentage in patients with X4R5 viruses than in those with R5 viruses (medians, 45% vs 35%, respectively; P = .10) and toward a negative correlation with the cumulative duration of HAART over the last 10 years (r = −0.263; P = .06). CD8 N percentage was not correlated with past HIV RNA levels or past immunosuppression (Table 2) .
CD4 RTE percentage was higher in female than in male patients (79% vs 73%, respectively; P = .002), and CMV-seropositive patients tended to have a lower CD4 RTE percentage than CMVseronegative patients (74% vs 79%; P = .11; Table 2 ). CD4 RTE percentage was positively correlated with nadir CD4 T-cell percentage and negatively correlated with the time for which CD4 T-cell percentage was <15% during the patient's lifetime (r = 0.456, P = .004; and r = −0.446, P = .004, respectively). CD4 RTE percentage was not associated with past HIV RNA levels or HIV coreceptor usage (Table 2) .
In multivariable analysis, CD4 N percentage was independently associated with CD4 T-cell count and X4 coreceptor usage and tended to be associated with cumulative viremia over the last 10 years, after adjustment for age and CDC stage ( Table 2 ). CD8 N percentage was independently associated with coreceptor usage and sex and tended to be associated with CD4 T-cell count after adjustment for age, CMV serostatus, and cumulative duration of HAART over the last 10 years. CD4 RTE percentage was independently associated with CD4 T-cell count, sex, and time for which CD4 T-cell percentage was <15% during the patient's lifetime, after adjustment for age and CMV serostatus.
Associations Between CD4 N , CD8 N , and CD4 RTE T-Lymphocyte Levels and HIV Disease History in Viremic Patients
In viremic patients, CD4 N and CD8 N percentages were directly correlated with CD4 T-cell count (r = 0.393, P = .04; and r = 0.749, P < .0001, respectively; Figure 1G -H) and with each other (r = 0.435; P = .02; Figure 1D ). CD4 N and CD8 N percentages were not correlated with plasma HIV-RNA level (r = −0.021, P = .91; and r = −0.285, P = .13, respectively). CD4 N percentage was not associated with demographic factors, viral characteristics or past HIV disease parameters (Table 3 ). CD8 N percentage was associated with CMV serostatus (medians, 27% vs 20% in seronegative and seropositive patients; P = .03) and negatively correlated with cumulative viremia over the last 10 years (r = −0.382; P = .04) and HIV-DNA level (r = −0.397; P = .04). CD4 RTE percentage was positively correlated with CD4 N percentage (r = 0.762; P = .0006; Figure 1E ) but not with CD8 N percentage (r = 0.132; P = .64; Figure 1F ). It was not correlated with CD4 T-cell count (r = −0.032; P = .90; Figure 1H ), plasma HIV-RNA level (r = −0.125; P = .62), or the other study variables.
In multivariable analysis, both CD4 N and the CD8 N percentages were independently associated only with CD4 T-cell count (Table 3) . In an alternative model, the CD8 N percentage was associated only with CD4 T-cell count after adjustment for age at nadir CD4 T-cell percentage, cumulative viremia, and CMV seropositivity (data not shown).
DISCUSSION
We found that >15 years after perinatal infection, naive CD4 Tlymphocyte levels and thymic activity were preserved and positively correlated with current CD4 T-cell count. High levels of viral replication and/or viral cytopathogenicity over the patient's lifetime were associated with higher levels of naive CD4 T lymphocytes at the time of the study.
The CD4 N percentages of our study population were in the range reported for uninfected individuals, corresponding to half to two-thirds of total CD4 T lymphocytes [14, 15] . CD4 RTE values were also similar to those reported for healthy young adults [16] . Our results extend those of a previous study on 20 perinatally infected youths on suppressive HAART, which reported normal levels of CD4 T-lymphocyte subsets and thymic activity [15] . CD8 N T-lymphocyte percentages were slightly lower than those reported for healthy young adults in our aviremic patients and were lower still in viremic patients [17] . The different patterns of CD4 and CD8 T-lymphocyte restoration reflect the more robust expansion of memory CD8 than of memory CD4 T lymphocytes in response to HIV replication, chemotherapy-induced lymphodepletion, and aging [6, 18, 19] .
CD4 RTE percentage was directly correlated with total CD4 Tlymphocyte count, as were the CD4 N and CD8 N percentages. In patients infected during adulthood, immune restoration involves both thymus-driven T-lymphocyte production and homeostatic proliferative expansion, and the failure of CD4 T-cell restoration despite prolonged viral suppression is associated with defective thymus function [20, 21] . Two of the 93 patients included in the ANRS-EP38-IMMIP study had current CD4 Tcell counts <350 cells/µL, despite being aviremic. One patient had recently experienced viral blips, whereas the other had remained continuously aviremic for >6 years and was, thus, the only patient that could have been classified as a "low CD4 responder" [21] . Overall, our results highlight the active role of the thymus in both qualitative and quantitative immune restoration in the patients studied.
One key finding of this study was that, in patients in which HIV replication was suppressed at the time of the study, higher CD4 N levels were associated with higher levels of viral replication in the previous 10 years. Furthermore, there was a trend toward higher CD4 N percentages in aviremic than in viremic patients. The results are expressed as percentages, and this association may therefore reflect either an increase in the production of naive T lymphocytes or higher levels of memory CD4 T-lymphocyte destruction in the presence of viral replication. In this second case, higher levels of viral replication would be associated with a higher CD4 N percentage and a lower CD4 Tcell count, and we would expect a negative correlation between CD4 N and CD4 T-cell count to be observed. By contrast, CD4 N percentage and CD4 T-cell count were positively correlated. Thus, the positive correlation between CD4 N percentage and cumulative viremia probably reflects higher levels of thymic output during previous periods of HIV replication. Indeed, high levels of thymic activity have been associated with high HIV RNA and HIV DNA levels in pediatric patients on HAART [22, 23] . A positive correlation between blood HIV DNA and T cell excision cycle (TREC) levels has been reported in children with treatment-induced viral suppression [24] . These findings have been interpreted as indicating that de novo T-lymphocyte production by the thymus is a homeostatic response to naive CD4 T-lymphocyte destruction and/or recruitment to the memory compartment driven by HIV replication. Our results are entirely consistent with this explanation and extend observations on children by showing the cumulative effect of viral replication on CD4 N T-lymphocyte levels >15 years after infection.
Among patients with suppressed viral replication, CD4 N and CD8 N percentages were higher in patients harboring X4R5 viruses than in those with R5 viruses. This association is counterintuitive because X4R5 viruses infect thymocytes and CD4 N T lymphocytes more efficiently than R5 viruses because of the more widespread expression of CXCR4 on these cells [20] . Given that these differences were observed only in aviremic patients, the detection of X4R5 viruses by cell-associated HIV DNA sequencing of archived virus may reflect past events, such as deeper immunosuppression associated with higher levels of viral replication and/or infection with more cytopathogenic viruses [25] . However, potent peripheral immune restoration has been observed in children with severe immunosuppression at treatment initiation [26] [27] [28] , and the association between CD4 N percentage and viral tropism is consistent with that between CD4 N percentage and cumulative viremia. CD4 RTE percentage was higher in viremic than in aviremic patients. This association may reflect the confounding effect of disease severity. However, viremic and aviremic youths did not differ in terms of previous occurrence of CDC stage C events, nadir CD4 T-cell percentage, or age at first HAART initiation (data not shown). In patients with active viral replication, CD4 RTE levels may increase because these cells are more resistant to HIV infection than their CD31-negative counterparts [29, 30] . Finally, this association may simply reflect an increase in thymic activity to maintain T-cell homeostasis in the presence of the virus, as discussed previously. In untreated adults, several studies have shown that active thymopoiesis occurs during the early asymptomatic phase of HIV infection, at levels greater than those in uninfected controls [31] [32] [33] . In the early HAART period, CD4 N T-lymphocyte reconstitution was reported in children with a partially reduced viral load [22, 34, 35] . Overall, our data suggest that thymic activity compensates for the destructive effect of viral replication, even after childhood. This result and the lack of correlation between age and CD4 RTE percentage contrast with the decline of blood thymic excision circles reported in uninfected teenagers and young adults [36] . Importantly, in patients with suppressed viral replication at the time of the study, CD4 RTE levels were negatively correlated with the duration of severe immunosuppression (ie, a CD4 T-cell percentage <15%), suggesting that the thymus remains active but has been damaged by past viral replication.
CD8 N and CD4 RTE levels were higher in female than in male patients, consistent with the higher levels of thymic activity reported for women than for men in studies of healthy donors [37, 38] . However, it remains unclear why CD4 N levels were not affected by sex. CMV infection induces a large expansion of memory T lymphocytes and a decrease in the size of the naive T-cell compartment [39] . CD8 N percentages were, indeed, lower in CMV-seropositive than in CMV-seronegative patients in univariable analysis. However, this association was not statistically significant in multivariable analysis.
One limitation of our study is that treatment status was heterogeneous in the viremic patients (HAART naive, HAART interruption, HAART without viral suppression). The small numbers of patients in each category precluded independent analysis. Therefore, comparisons of patients with and without viral suppression should be interpreted with caution. The associations between higher levels of viral replication and higher levels of naive T lymphocytes were convincingly confirmed by analyses of viral history in patients who were aviremic at the time of the study. CD31 expression on naive CD4 T cells is a convenient but imperfect marker of thymic activity. CD4 RTE cells may undergo proliferation in the periphery before losing CD31 expression, a process subject to interindividual and agedependent variation [40] . However, limitations on the volumes of blood that can be drawn from adolescents have limited our ability to perform additional tests, such as TREC or telomere length assessment. For the same reasons, CD4 RTE data from frozen peripheral blood mononuclear cell samples were available for only 60% of the patients, reducing the statistical power of the analyses.
Our data for this first generation of patients infected with HIV in the perinatal period without early access to HAART are encouraging for the future clinical management of these patients. They are also consistent with the good health status reported for perinatally infected youths living in France [1] . The paradoxically high level of thymic activity in subjects with sustained viral replication provides an argument for longitudinal follow-up of the naive T-cell compartment in these perinatally infected youths.
Notes
